Tejnaksh Healthcare (TEJNAKSH): Board Meeting

Board Meeting 1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the C

1 min read Tejnaksh Healthcare

Board Meeting

Board Meeting

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1, 2026, and ending on March 31, 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue, in view of the postponement of the Company's expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1, 2026, and ending on March 31, 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue, in view of the postponement of the Company's expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Tejnaksh Healthcare Ltd #TEJNAKSH #Corporate announcement

Live Updates

Quick Notification

AI Insights

Smart analysis of market trends

Smart Alerts

Notifications on crucial events

WhatsApp & Telegram

Alerts in the chat you already use

FREE PLAN · PAID UPGRADES FROM ₹89/MO

Track Indian stocks with ZTOX AI

NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.

Free 5 companies
Basic 20 companies
Pro Up to 500 companies
A

"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."

— Aditya M., Active Trader